These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 19645854)
1. Zileuton prevents the activation of the leukotriene pathway and reduces sebaceous lipogenesis. Zouboulis CC; Seltmann H; Alestas T Exp Dermatol; 2010 Feb; 19(2):148-50. PubMed ID: 19645854 [TBL] [Abstract][Full Text] [Related]
2. Zileuton, a new efficient and safe systemic anti-acne drug. Zouboulis CC Dermatoendocrinol; 2009 May; 1(3):188-92. PubMed ID: 20436887 [TBL] [Abstract][Full Text] [Related]
3. Regulation of stearoyl-coenzyme A desaturase and fatty acid delta-6 desaturase-2 expression by linoleic acid and arachidonic acid in human sebocytes leads to enhancement of proinflammatory activity but does not affect lipogenesis. Zouboulis CC; Angres S; Seltmann H Br J Dermatol; 2011 Aug; 165(2):269-76. PubMed ID: 21457203 [TBL] [Abstract][Full Text] [Related]
4. Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. Alestas T; Ganceviciene R; Fimmel S; Müller-Decker K; Zouboulis CC J Mol Med (Berl); 2006 Jan; 84(1):75-87. PubMed ID: 16388388 [TBL] [Abstract][Full Text] [Related]
5. Resveratrol ameliorates lipid accumulation and inflammation in human SZ95 sebocytes via the AMPK signaling pathways in vitro. Wei Z; Chen G; Hu T; Mo X; Hou X; Cao K; Wang L; Pan Z; Wu Q; Li X; Ye F; Zouboulis CC; Ju Q J Dermatol Sci; 2021 Sep; 103(3):156-166. PubMed ID: 34334258 [TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton. Rao NL; Dunford PJ; Xue X; Jiang X; Lundeen KA; Coles F; Riley JP; Williams KN; Grice CA; Edwards JP; Karlsson L; Fourie AM J Pharmacol Exp Ther; 2007 Jun; 321(3):1154-60. PubMed ID: 17371808 [TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3-gallate suppresses IGF-I-induced lipogenesis and cytokine expression in SZ95 sebocytes. Im M; Kim SY; Sohn KC; Choi DK; Lee Y; Seo YJ; Kim CD; Hwang YL; Zouboulis CC; Lee JH J Invest Dermatol; 2012 Dec; 132(12):2700-8. PubMed ID: 22763784 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological PPARγ modulation regulates sebogenesis and inflammation in SZ95 human sebocytes. Mastrofrancesco A; Ottaviani M; Cardinali G; Flori E; Briganti S; Ludovici M; Zouboulis CC; Lora V; Camera E; Picardo M Biochem Pharmacol; 2017 Aug; 138():96-106. PubMed ID: 28461124 [TBL] [Abstract][Full Text] [Related]
9. Nicotinic acid suppresses sebaceous lipogenesis of human sebocytes via activating hydroxycarboxylic acid receptor 2 (HCA Markovics A; Tóth KF; Sós KE; Magi J; Gyöngyösi A; Benyó Z; Zouboulis CC; Bíró T; Oláh A J Cell Mol Med; 2019 Sep; 23(9):6203-6214. PubMed ID: 31273921 [TBL] [Abstract][Full Text] [Related]
10. Differentially regulated microRNAs during human sebaceous lipogenesis. Schneider MR; Samborski A; Bauersachs S; Zouboulis CC J Dermatol Sci; 2013 May; 70(2):88-93. PubMed ID: 23452545 [TBL] [Abstract][Full Text] [Related]
11. Autophagy regulates lipid production and contributes to the sebosuppressive effect of retinoic acid in human SZ95 sebocytes. Seo SH; Jung JY; Park K; Hossini AM; Zouboulis CC; Lee SE J Dermatol Sci; 2020 May; 98(2):128-136. PubMed ID: 32354609 [TBL] [Abstract][Full Text] [Related]
12. ALA-PDT suppressing the cell growth and reducing the lipogenesis in human SZ95 sebocytes by mTOR signaling pathway in vitro. Tuo J; Wang Q; Zouboulis CC; Liu Y; Ma Y; Ma L; Ying J; Zhang C; Xiang L Photodiagnosis Photodyn Ther; 2017 Jun; 18():295-301. PubMed ID: 28330814 [TBL] [Abstract][Full Text] [Related]
13. Effects of Extracellular Calcium and 1,25 dihydroxyvitamin D3 on Sebaceous Gland Cells In vitro and In vivo. Zouboulis CC; Seltmann H; Abdel-Naser MB; Hossini AM; Menon GK; Kubba R Acta Derm Venereol; 2017 Mar; 97(3):313-320. PubMed ID: 27572620 [TBL] [Abstract][Full Text] [Related]
14. Allergen-stimulated leukotriene B4 and interleukin-8 levels in patients with asthma and allergic rhinitis-modulation by a lipid pathway inhibitor. Frieri M; Therattil JM; Zitt M; Bouboulis D; Wang SF; Lark G; Schaefer PA; Sansone G Ann Allergy Asthma Immunol; 1998 Oct; 81(4):331-6. PubMed ID: 9809497 [TBL] [Abstract][Full Text] [Related]
15. TNF-α increases lipogenesis via JNK and PI3K/Akt pathways in SZ95 human sebocytes. Choi JJ; Park MY; Lee HJ; Yoon DY; Lim Y; Hyun JW; Zouboulis CC; Jin M J Dermatol Sci; 2012 Mar; 65(3):179-88. PubMed ID: 22305016 [TBL] [Abstract][Full Text] [Related]
16. Leptin promotes a proinflammatory lipid profile and induces inflammatory pathways in human SZ95 sebocytes. Törőcsik D; Kovács D; Camera E; Lovászi M; Cseri K; Nagy GG; Molinaro R; Rühl R; Tax G; Szabó K; Picardo M; Kemény L; Zouboulis CC; Remenyik É Br J Dermatol; 2014 Dec; 171(6):1326-35. PubMed ID: 24975960 [TBL] [Abstract][Full Text] [Related]
17. Assessment of in vivo 5-lipoxygenase activity by analysis of leukotriene B4 in saliva: effects of treatment with zileuton. Gaber F; James A; Delin I; Wetterholm A; Sampson AP; Dahlén B; Dahlén SE; Kumlin M J Allergy Clin Immunol; 2007 May; 119(5):1267-8. PubMed ID: 17258303 [No Abstract] [Full Text] [Related]
18. Role of 5-lipoxygenase pathway in the regulation of RAW 264.7 macrophage proliferation. Nieves D; Moreno JJ Biochem Pharmacol; 2006 Oct; 72(8):1022-30. PubMed ID: 16934759 [TBL] [Abstract][Full Text] [Related]
19. Intrinsic 5-lipoxygenase activity is required for neutrophil responsivity. Guidot DM; Repine MJ; Westcott JY; Repine JE Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8156-9. PubMed ID: 8058773 [TBL] [Abstract][Full Text] [Related]
20. Expression of Protease-Activated Receptor-2 in SZ95 Sebocytes and its Role in Sebaceous Lipogenesis, Inflammation, and Innate Immunity. Lee SE; Kim JM; Jeong SK; Choi EH; Zouboulis CC; Lee SH J Invest Dermatol; 2015 Sep; 135(9):2219-2227. PubMed ID: 25880702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]